Accelerate Diagnostics Stock Probability of Future Stock Price Finishing Over 13.72
| AXDX Stock | USD 1.18 0.01 0.84% |
Accelerate |
Accelerate Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Accelerate Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Accelerate Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Accelerate Diagnostics generated a negative expected return over the last 90 days | |
| Accelerate Diagnostics may become a speculative penny stock | |
| Accelerate Diagnostics has high historical volatility and very poor performance | |
| Accelerate Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.06 M. Net Loss for the year was (61.62 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| Accelerate Diagnostics currently holds about 36.77 M in cash with (40.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45. | |
| Accelerate Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Roughly 38.0% of the company shares are held by company insiders |
Accelerate Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Accelerate Stock often depends not only on the future outlook of the current and potential Accelerate Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Accelerate Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.5 M | |
| Cash And Short Term Investments | 13.2 M |
Accelerate Diagnostics Technical Analysis
Accelerate Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Accelerate Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Accelerate Diagnostics. In general, you should focus on analyzing Accelerate Stock price patterns and their correlations with different microeconomic environments and drivers.
Accelerate Diagnostics Predictive Forecast Models
Accelerate Diagnostics' time-series forecasting models is one of many Accelerate Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Accelerate Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Accelerate Diagnostics
Checking the ongoing alerts about Accelerate Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Accelerate Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Accelerate Diagnostics generated a negative expected return over the last 90 days | |
| Accelerate Diagnostics may become a speculative penny stock | |
| Accelerate Diagnostics has high historical volatility and very poor performance | |
| Accelerate Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.06 M. Net Loss for the year was (61.62 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| Accelerate Diagnostics currently holds about 36.77 M in cash with (40.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45. | |
| Accelerate Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Roughly 38.0% of the company shares are held by company insiders |
Additional Tools for Accelerate Stock Analysis
When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.